Vestcor Inc Reduces Stock Holdings in Encompass Health Corporation $EHC

Vestcor Inc reduced its holdings in Encompass Health Corporation (NYSE:EHC) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 80,345 shares of the company’s stock after selling 5,568 shares during the period. Vestcor Inc’s holdings in Encompass Health were worth $8,528,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in EHC. AlphaCore Capital LLC acquired a new position in shares of Encompass Health in the 4th quarter valued at $4,881,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after acquiring an additional 3,793,358 shares during the period. Tudor Investment Corp ET AL increased its holdings in shares of Encompass Health by 155.3% in the 3rd quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock valued at $26,765,000 after acquiring an additional 128,191 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Encompass Health by 5.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after acquiring an additional 70,387 shares during the period. Finally, SG Americas Securities LLC increased its holdings in shares of Encompass Health by 1,070.9% in the 4th quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock valued at $9,346,000 after acquiring an additional 80,534 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on EHC shares. Barclays cut their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Leerink Partners set a $152.00 target price on shares of Encompass Health in a report on Friday, May 22nd. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, TD Cowen started coverage on shares of Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $143.86.

Encompass Health Stock Performance

Shares of EHC opened at $104.39 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a market capitalization of $10.36 billion, a P/E ratio of 17.43, a P/E/G ratio of 2.18 and a beta of 0.72. The company’s fifty day moving average is $103.79 and its two-hundred day moving average is $105.01. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. Encompass Health’s revenue was up 9.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, sell-side analysts predict that Encompass Health Corporation will post 5.97 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 12.69%.

Insiders Place Their Bets

In other news, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at $9,557,775. This represents a 11.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.